Author Details

Fadeeva, Natalia V.

Issue Section Title File
Vol 23, No 1 (2021) CLINICAL ONCOLOGY Analysis of the efficacy and safety of eribulin therapy in patients with HR+/HER2- metastatic breast cancer pretreated with CDK4/6 inhibitors in real Russian practice PDF
(Rus) PDF
(Eng)
Vol 23, No 4 (2021) CLINICAL ONCOLOGY Multicenter prospective observational post-approval study of safety and efficacy of bevacizumab (Avegra®, BIOCAD) in patients with metastatic colorectal cancer in real world practice: APOLLON-11 and SOYUZ-APOLLON PDF
(Rus)
Vol 24, No 1 (2022) CLINICAL ONCOLOGY Effectiveness and safety of empegfilgrastim (Extimia®, BIOCAD) in patients with lymphoproliferative diseases who receive cytotoxic therapy: results of LEGERITY, the second interim analysis of multicenter retrospective-and-prospective observational post-marketing study PDF
(Rus)
Vol 25, No 3 (2023) CLINICAL ONCOLOGY Efficacy and safety of nurulimab+prolgolimab with continued prolgolimab therapy compared to prolgolimab alone as first-line therapy in patients with unresectable or metastatic melanoma: final results of the phase II OBERTON clinical study PDF
(Rus)
Vol 25, No 4 (2023) CLINICAL ONCOLOGY Effectiveness and safety of empegfilgrastim (Extimia®, BIOCAD) in patients with lymphoproliferative diseases receiving cytotoxic therapy: results of LEGERITY, a multicenter retrospective-and-prospective observational post-marketing study PDF
(Rus)
Vol 26, No 1 (2024) Articles Safety and efficacy of ribociclib in combination with letrozole in an extended population of patients with HR+/HER2- advanced breast cancer: analysis of data from a subgroup of patients from Russia in the phase lllb CompLEEment-1 study PDF
(Rus)

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies